As of 3:59pm ET
| 0.0001 / +0.00%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +96.08% increase from the last price of 2.55.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.